<DOC>
	<DOCNO>NCT01395901</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy single palonosetron IV dose compare single ondansetron IV dose prevention postoperative nausea vomit 24 hour surgery child age neonate less 17 year undergoing elective surgical procedure require general intravenous anesthesia . The secondary objective evaluate safety tolerability IV palonosetron pediatric patient .</brief_summary>
	<brief_title>Safety Efficacy Palonosetron IV Prevent Postoperative Nausea Vomiting Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Male female patient age full term neonate le 17 year . Inpatient outpatient schedule undergo one follow procedure : ear , nose throat surgery ( e.g. , tonsillectomy , adenoidectomy , myringotomy ) , eye surgery ( e.g . strabismus , vitreoretinal , cataract surgery ) , urological surgery ( e.g . orchidopexy , varicocoele ) , plastic reconstructive surgery ( e.g . cleft lip/cleft palate , burn procedure involve scalp ) , hernia repair , orthopedic surgery ( e.g . foot ankle deformity , arthroscopic surgery , ACL surgery ) , . cardiac surgery , neurosurgery . Patient schedule undergo surgery require general intravenous anesthesia Patient schedule receive nitrous oxide maintenance phase anesthesia Patient weigh least 3.2 kg ASA physical status I , II III Fertile patient ( male female ) must use reliable contraceptive measure Female patient attain menarche must negative pregnancy test screen visit ( Visit 1 ) study treatment visit ( Visit 2 ) For patient know hepatic impairment : Investigator 's opinion , impairment jeopardize patient 's safety study For patient know renal impairment : Investigator 's opinion , impairment jeopardize patient 's safety study Lactating females Patient age â‰¤6 year receive investigational drug within 90 day prior Day 1 , patient age &gt; 6 year receive investigational drug within 30 day prior Day 1 expect receive investigational drug prior study completion . Patient participate previous trial palonosetron . History allergy component contraindication use 5HT3 receptor antagonist Patient undergo emergency surgery Patient schedule receive regional anesthesia ( lumbar , epidural , spinal ) alone conjunction general intravenous anesthesia Patient schedule receive laryngeal mask anesthesia Patient schedule receive propofol maintenance phase anesthesia Patient suffering concomitant disease uncontrolled therapy , , judgment Investigator , could compromise outcome surgery Patient history gastroesophageal reflux ( except patient 12 month ) Patient ongoing vomit organic cause Patient experience vomit , retch , nausea within 24 hour prior administration study drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Prevention Postoperative Nausea Vomiting</keyword>
	<keyword>Palonosetron</keyword>
	<keyword>Ondansetron</keyword>
	<keyword>Pediatric</keyword>
</DOC>